| Literature DB >> 30062095 |
Inga I Hitzeroth1, Aleyo Chabeda1, Mark P Whitehead1, Marcus Graf2, Edward P Rybicki1,3.
Abstract
Human papillomaviruses (HPVs) are the causative agents of cervical cancer, the fourth most prevalent cancer in women worldwide. The major capsid protein L1 self-assembles into virus-like particles (VLPs), even in the absence of the minor L2 protein: such VLPs have successfully been used as prophylactic vaccines. There remains a need, however, to develop cheaper vaccines that protect against a wider range of HPV types. The use of all or parts of the L2 minor capsid protein can potentially address this issue, as it has sequence regions conserved across several HPV types, which can elicit a wider spectrum of cross-neutralizing antibodies. Production of HPV VLPs in plants is a viable option to reduce costs; the use of a L1/L2 chimera which has previously elicited a cross-protective immune response is an option to broaden cross-protection. The objective of this study was to investigate the effect of codon optimization and of increasing the G+C content of synthetic L1/L2 genes on protein expression in plants. Additionally, we replaced varying portions of the 5' region of the L1 gene with the wild type (wt) viral sequence to determine the effect of several negative regulatory elements on expression. We showed that GC-rich genes resulted in a 10-fold increase of mRNA levels and 3-fold higher accumulation of proteins. However, the highest increase of expression was achieved with a high GC-content human codon-optimized gene, which resulted in a 100-fold increase in mRNA levels and 8- to 9-fold increase in protein levels. Changing the 5' end of the L1 gene back to its wt sequence decreased mRNA and protein expression. Our results suggest that the negative elements in the 5' end of L1 are inadvertently destroyed by changing the codon usage, which enhances protein expression.Entities:
Keywords: HPV-16; L1; L1/L2chimera; codon usage; plant expression; regulatory elements
Year: 2018 PMID: 30062095 PMCID: PMC6054922 DOI: 10.3389/fbioe.2018.00101
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Figure 1Schematic representation of L1 chimeras (A) L1/L2 gene showing various elements found on the gene. The first 514 nucleotides contain elements that regulate gene expression. L2 epitope indicates the replacement of amino acids on the L1 protein with L2 108–120. (B) Enlargement of the L1 regulatory region from 1 to 514 showing position of enhancer regions, enhancer elements and negative elements. (C) Schematic representation of the 5 wt/L1/L2 chimeras. Red gene regions are from wt L1 while blue elements are from the high-GC content L1 construct.
Summary of genes with varying GC content.
| 38.27% (WT) | Wild type gene – HPV codon usage | Yes | |
| 34.64% (BT) | Tobacco codon optimization (TCO) | Yes | |
| 50.88% | TCO with elevated GC content | Yes | |
| 61.01% | TCO with elevated GC content | Yes | |
| 43.06% (CpG) | TCO with elevated CpG dinucleotides | Yes | |
| 62.52% | Human codon optimized | Yes | |
| 62.20% (hL1) | Human codon optimized | No |
Primers used in plasmid construction.
| ChiF F | 5′-ACTGCAGACGTTATGACATAC-3′ | 1,170 | 99 |
| ChiF R | 5′-TTCCACTAATGTGCCTCCTG-3′ | 1,229 | |
| SAF-2 F | 5′-ACCAGGTGGAACTCTTGTTG-3′ | 1,298 | 97 |
| SAF-2 R | 5′-AGTGGATCTTCCTTTGGAGC-3′ | 1,355 | |
| SAF-3 F | 5′-CGATCTCCAGTTCATCTTCC-3′ | 1,181 | 100 |
| SAF3 R | 5′-TTCCAATCCTCAAGGATAGTG-3′ | 1,240 | |
| SAF-4 F | 5′-AAGAGTACGACCTCCAGTTC-3′ | 1,195 | 96 |
| SAF-4 R | 5′-AAGGATGGTGGAGTTCATGG-3′ | 1,251 | |
| SAF-5 F | 5′-TACTCTTCAAGCTAATAAGTCC-3′ | 727 | 105 |
| SAF-5 R | 5′-AAGAATCGCCGTATGGTTCG-3′ | 790 | |
| SAF F | 5′-ACTTCAAGGAGTACCTGAGG-3′ | 1,152 | 103 |
| SAF R | 5′-TGTGGATGTAGGTCATCACG-3′ | 1,215 | |
| SAF F66 | 5′-AGTATCTAAGGTTGTAAGCACCGATGAGTACGTGG-3′ | ||
| Chi F R66 | 5′-ACGTACTCATCGGTGCTTACAACCTTAGATACTGG-3′ | ||
| SAF F147 | 5′-AGTTGGACATCCCTATTTCCCCATCAAGAAGC-3′ | ||
| ChiFR147 | 5′-CTTCTTGATGGGGAAATAGGGATGTCCAACTGC-3′ | ||
| SAF F251 | 5′-TGACCCCAATAAGTTTGGCTTCCCCGACACCAGC-3′ | ||
| ChiF R251 | 5′-TGGTGTCGGGGAAGCCAAACTTATTGGGGTCAGG-3′ | ||
| SAF F429 | 5′-CAGGTGTGGATAACAGAGAATGCATCAG-3′ | ||
| ChiF R429 | 5′-CTGATGCATTCTCTGTTATCCACACCTGCATTTGC-3′ | ||
| SAF F620 | 5′-GTTGATACTGGCTTTGGTGCCATGGACTTCACCACC-3′ | ||
| ChiF R 620 | 5′-GTGGTGAAGTCCATGGCACCAAAGCCAGTATCAACC-3′ |
Figure 2Comparative expression of L1/L2 and hL1 with different GC contents using pTRAc and pTRAkc rbcs1-CTP (CTP). Protein was expressed with or without NSs and extracted 5dpi. (A) Western blot detection of L1/L2 and hL1. MW, molecular weight marker, arrow indicates position of L1 and L1/L2 proteins. Equal volumes of sample were loaded. (B) Protein yield as mg/kg fresh weight determined by capture ELISA. Results represent 3 biological repeats, error bars indicate ±SEM. (C) Comparison of RNA transcription levels of L1 and chimeras targeted to different subcellular locations. mRNA levels were measured as ratio of 18S RNA to normalize for extraction variation.
Figure 3Comparative expression of wt/L1/L2 with L1/L2 and L1 using pTRAc and pTRAkc rbcs1-CTP (CTP). (A) Western blot detection of wt/L1/L2, L1/L2, and L1. MW, molecular weight marker, arrow indicates position of L1, L1/L2, and wt/L1/L2 proteins. Equal volumes of sample were loaded. (B) Protein yield as mg/kg fresh weight determined by capture ELISA. Results represent 3 biological repeats, error bars indicate ±SEM. (C) Comparison of RNA transcription levels of L1 and chimeras targeted to different subcellular locations. mRNA levels were measured as ratio of 18S RNA to normalize for extraction variation.